Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Assets: 2013-2024

Historic Assets for Fortress Biotech (FBIO) over the last 12 years, with Dec 2024 value amounting to $144.2 million.

  • Fortress Biotech's Assets rose 42.74% to $181.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $181.4 million, marking a year-over-year increase of 42.74%. This contributed to the annual value of $144.2 million for FY2024, which is 13.91% down from last year.
  • Latest data reveals that Fortress Biotech reported Assets of $144.2 million as of FY2024, which was down 13.91% from $167.5 million recorded in FY2023.
  • Fortress Biotech's Assets' 5-year high stood at $396.5 million during FY2021, with a 5-year trough of $144.2 million in FY2024.
  • For the 3-year period, Fortress Biotech's Assets averaged around $202.0 million, with its median value being $167.5 million (2023).
  • Per our database at Business Quant, Fortress Biotech's Assets soared by 47.25% in 2020 and then crashed by 43.08% in 2023.
  • Over the past 5 years, Fortress Biotech's Assets (Yearly) stood at $333.4 million in 2020, then grew by 18.92% to $396.5 million in 2021, then dropped by 25.78% to $294.3 million in 2022, then tumbled by 43.08% to $167.5 million in 2023, then fell by 13.91% to $144.2 million in 2024.